Exiqon 2013 Revenues Rise 5 Percent Despite a 16 Percent Drop in Q4 | GenomeWeb

NEW YORK (GenomeWeb News) – Exiqon today reported a 5 percent increase year over year in its revenues for 2013, while revenues in its fourth quarter shrank 16 percent.

The Danish firm said that total revenues in 2013 grew to DKK123.6 million ($22.6 million) from DKK117.4 million in 2012. Life Sciences revenues rose 6 percent to DKK118.4 million from DKK111.3 million, offsetting a 15 percent drop in Diagnostics revenues to DKK5.2 million from DKK6.1 million, Exiqon said in its annual report.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.